Skip to main content
. 2022 Nov 18;23(1):142. doi: 10.1186/s10194-022-01515-8

Table 3.

Patients with ≥ 10 or < 10 acute migraine-specific medication days

Acute Migraine-Specific Medication Days Baseline
N = 145 (100%)
Month 6
N = 113 (100%)
 ≥ 10 81 (55.9%) 27 (23.9%)
 < 10 64 (44.1%) 86 (76.1%)